Genea Biocells Expands Operations Center In San Diego, California
Genea Biocells' new premises include office and laboratory space to accommodate the company's cell and culture media manufacturing, research services and R&D. According to the firm, the move represents a substantial investment in California with the new site housing over $2 million worth of equipment, including sophisticated robotics and instrumentation for screening.
The site is expected to be fully operational from September 2015 and by early 2016 will house up to 15 scientists. "This is an exciting strategic move and the next step to grow Genea Biocells into a world leading stem cell company. The new facility not only places us directly into our main market, the USA, but also in the midst of one of the largest biotechnology clusters in the world," Genea Biocells General Manager Dr. Uli Schmidt said.
"Being in California also offers a new range of funding opportunities that we will explore to support our R&D programs on neuromuscular diseases,” he added.
Why are Foreign Trade Zones Making a Comeback?
The New Normal in the Automotive Supply Chain
2020 Auto/Aero Site Guide
34th Annual Corporate Survey & the 16th Annual Consultants Survey
Infrastructure Investment as an Economic Stimulus Tool
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
Nondisclosure Agreements Best Practices When Negotiating Incentives